Identification of HLA-A2 or HLA-A24-restricted CTL epitopes for potential HSP105-targeted immunotherapy in colorectal cancer

By                        

Oncology Reports, Vol. 31, Iss. 3, 2014-01 ,pp. : 1051-1058

Spandidos Publications

Access to resources Recommend Favorite

Identification of HER2/neu-Derived Peptides Capable of Inducing both Cellular and Humoral Immune Responses in HLA-A24 Positive Breast Cancer Patients

By Azuma Koichi   Shichijo Shigeki   Shomura Hiroki   Matsueda Satoko   Fujii Teruhiko   Itoh Kyogo  

Breast Cancer Research and Treatment, Vol. 86, Iss. 1, 2004-07 ,pp. : 19-29

Springer Publishing Company

Access to resources Recommend Favorite

Correlation between HLA-A2 gene frequency, latitude, ovarian and prostate cancer mortality rates

By De Petris Luigi   Bergfeldt Kjell   Hising Christina   Lundqvist Andreas   Tholander Bengt   Pisa Pavel   Zanden Henk   Masucci Giuseppe  

Medical Oncology, Vol. 21, Iss. 1, 2004-03 ,pp. : 49-52

Humana Press, Inc

Access to resources Recommend Favorite

Studies of HLA-A and DR Locus Deletions in Human Liver Cancer Cell Lines by PCR

By Qing L.   S. H.C.   E. C.R.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 371-372

Elsevier

Access to resources Recommend Favorite

Identification of new prostate stem cell antigen-derived peptides immunogenic in HLA-A2⁺ patients with hormone-refractory prostate cancer

By Matsueda Satoko   Kobayashi Kazuhiko   Nonaka Yoichi   Noguchi Masanori   Itoh Kyogo   Harada Mamoru  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 6, 2004-06 ,pp. : 479-489

Springer Publishing Company

Access to resources Recommend Favorite